Showing results (1851-1860 of 3,162) with videos related to

Sort By:
Pageof 317
Prosthetics and Orthotics International|October 24, 2003
New technical advances in swivel walkersJ Stallard, B Lomas, P Woollam, et al.
Journal of Immunological Methods|March 1, 2003
Evaluation of antigen-specific responses using in vitro enriched T cellsN Jones, D Agrawal, M Elrefaei, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolatesM A Pfaller, D J Diekema, S A Messer, et al.
Chemical Communications (Cambridge, England)|December 3, 2003
Isolation of C-H...C(pi) complexes from the reaction of stable carbenes with hydrocarbonsSilvia Filipponi, Jamie N Jones, Jennifer A Johnson, et al.
Journal of Clinical Microbiology|November 1, 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersH S Sader, M A Pfaller, F C Tenover, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1987
Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibodyM B Brenner, J McLean, H Scheft, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2008
Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serumBrian T Tsuji, Steven N Leonard, Paul R Rhomberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2002
Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)Ronald N. Jones, Matthew A.T. Croco, Michael A. Pfaller, et al.
Pageof 317